Enthusiasm and regard for the pace at which the life sciences are advancing drive Kim, a co-chair of Cooley’s global capital markets practice group. His clients are vast—he worked on Uber Technologies Inc.’s $8.1 billion IPO in 2019—but the convergence of medical technology and health care that fired his recent deals.
Since 2019 alone, Kim was involved in more than 100 successful public company securities offeri...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In